Early Findings of AI Study at Frimley Health NHS Foundation Trust Show 99.7% Accuracy in Triaging Chest X-rays as Normal

Qure.aiFrimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).

qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency. The aim of the study was to highlight AI’s potential role in optimising radiology department workflows, to boost efficiency and enhance patient outcomes.

Early results show 99.7% accuracy in triaging CXRs as normal, with the potential to reduce consultant radiologist’s workload by up to 58% by transferring cases to radiographer reporting workload. This could save consultant radiologists up to 2 hours per day, freeing up time to concentrate on specialist and complex imaging reports.

Additionally, the qXR AI identified all cancer cases, including inconspicuous cancer risk nodules that may traditionally remain unnoticed. This heralds the potential of using AI for early detection and treatment of lung cancer.

Dr Amrita Kumar, Consultant Radiologist and AI Clinical Lead at Frimley Health NHS Foundation Trust states, "AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure's qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department."

Darren Stephens, Senior Vice President & Commercial Head UK and Europe of Qure.ai comments, "The ongoing radiologist shortage, now estimated by Royal College of Radiologists to be 40% by 2027, underscores the importance of healthcare AI to help augment the precious human resource that currently exists, and ensure the delivery of the highest standard of patient care into the future. The qXR study at Frimley Health NHS Foundation Trust is testimony to the clinical leadership at the Trust in embracing AI as an opportunity for positive change."

For further information, please visit:
https://qure.ai

About Qure.ai

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible and affordable to patients around the world in medical imaging & care coordination. Our technology fulfils a pertinent, unmet need in the radiology industry. With the aid of tools like those developed by Qure.ai, which work via a sophisticated set of algorithms that can instantly evaluate scans to prioritize actionable patient cases quickly, radiologists can focus their time and advanced skill sets on the most pressing diagnoses.

Most Popular Now

AI Harnesses Tumor Genetics to Predict T…

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one...

Northern Care Alliance Deploys Digital P…

The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that...

American College of Radiology Releases J…

The American College of Radiology® (ACR®), working in close collaboration with four other radiology societies from around the world, have issued a joint statement on the development and use of...

Nine Tasks and One Big Challenge for Sha…

Opinion Article by Mark Hindle, vice president EMEA, Orion Health,. It's going to be a busy year in the shared care records space. NHS leaders, ShCRs and their suppliers are going...

Autonomous Synthesis Robot Uses AI to Sp…

Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human...

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbrücken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...